Our November issue is live! Bringing the Human Story to AI with Immunai's Noam Solomon ??Retooling the ‘Gene’ Value Machine??Powering Pipelines Forward??New Tricks to Solve Age-Old Problems??and so much more right here: https://lnkd.in/eDntPy65
关于我们
Pharmaceutical Executive provides its audience of pharmaceutical and biopharmaceutical executives with the analysis of business, strategy, and government regulations. We go beyond the news and provide in-depth analysis to help executives navigate through the maze of policy and business challenges that face this industry. We do it through the review of the issues, interviews, and roundtable discussions with thought leaders and business leaders.
- 网站
-
https://www.pharmexec.com/
Pharmaceutical Executive的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 11-50 人
- 总部
- Iselin，New Jersey
- 类型
- 私人持股
- 领域
- Publishing、Pharmaceutical News和Biopharmaceutical News
地点
-
主要
获取路线
US，New Jersey，Iselin，07072
Pharmaceutical Executive员工
动态
-
In a recent interview with Pharmaceutical Executive, our VP of Ad Partnerships and Strategy, Theodore Sweetser, shares how the rise of data privacy regulations and the decline of third-party cookies has healthcare advertisers facing new challenges. ?? Ted highlights how real-world data can help by combining advanced analytics and privacy-compliant targeting, allowing healthcare advertisers to deliver more effective, patient-centric campaigns without relying on traditional cookie-based tracking. Watch Ted’s interview here and learn how PurpleLab is helping advertisers stay ahead of the curve in a privacy-first world. ?? https://lnkd.in/eBseFwZf #HealthcareAdvertising #DataPrivacy #RealWorldData #AdvertisingInnovation #DigitalMarketing #PrivacyCompliance #RWD #HealthcareMarketing
-
-
This Pharmaceutical Executive article underscores the critical shift specialties must make toward #valuebasedcare. At BettrAi LLC, we see this as an exciting opportunity to harness the power of #AI-driven insights to address rising-risk and high-risk populations more effectively. By empowering providers with #actionabledata, we can help specialty practices not only reduce costs but also elevate patient outcomes. Transitioning to value-based care is complex, but with the right tools and strategies, it becomes a pathway to more sustainable, impactful #caredelivery. READ ARTICLE??https://lnkd.in/eJG6-24i
Specialty Value-Based Care is Improving Health Outcomes While Reducing Heath Care Costs
pharmexec.com
-
The Biden-Harris Administration announced a proposed rule aimed at expanding #Medicare and #Medicaid coverage for anti-obesity medications (AOMs), including #Ozempic and #Wegovy, from Novo Nordisk, and #Mounjaro and #Zepbound, from Eli Lilly and Company.
Biden-Harris Administration Proposes Expansion to Medicare and Medicaid to Include Anti-Obesity Medications
pharmexec.com
-
The sector's XBI is up 15% year-to-date; rate cuts, election outcome, and M&A are viewed as tailwinds ???Barbara Ryan
Biotech Investor Sentiment Climbing Steadily, with Growing Enthusiasm Heading into 2025
pharmexec.com
-
Pathway is now the first and only FDA-approved companion diagnostic for identifying HER2-positive biliary tract cancer patients eligible for treatment with #Ziihera
FDA Expands Labelling for Roche’s Pathway Rabbit Monoclonal Primary Antibody in Patients with Biliary Tract Cancer
pharmexec.com
-
Children's Hospital of Philadelphia's #CelloType produces more accurate results when analyzing high content tissue images.
Children’s Hospital of Philadelphia Announces New Imaging AI Technology
pharmexec.com